A phenotype for genetic studies of successful cognitive aging *

Survival from Alzheimer's disease (AD) and other dementias into late old age may be a useful phenotype for genetic studies of successful cognitive aging. To support molecular genetics studies for successful cognitive aging, we conducted a two‐stage study to determine an optimal age phenotype for successful cognitive aging. First, risk of AD was evaluated, through informant interviews, in 4,794 parents and siblings of 976 elderly nondemented probands who were divided into three different proband age groups: those aged 60–74, 75–89, and 90+. Relatives of probands aged 90+ had a significantly lower risk than the relatives of the other two proband groups. Second, this sample was combined with an earlier sample (combined nondemented elderly probands: n = 2,025; relatives: n = 10,506), and a series of proband age groups (i.e., 75–79, 80–84, 85–89, 90+) were used to determine which optimally identifies a group of relatives with low AD risk. Using the relatives of the nondemented proband aged 60–74 as the reference group, there were reductions in cumulative risk among relatives of probands aged 85–89 and 90+, but only the latter group also showed significant reductions to the relatives of probands aged 75–79, 80–84, and 85–89. This pattern of results varied little by sex. Finally, cumulative AD risk curves were similar between relatives of probands aged 90–94 and 95+. These results suggest that age 90 is an optimal age threshold to use for both men and women in genetic studies seeking to identify genes associated with successful cognitive aging. © 2007 Wiley‐Liss, Inc.

[1]  N. Pedersen,et al.  Surprising Lack of Sex Differences in Normal Cognitive Aging in Twins , 2006, International journal of aging & human development.

[2]  Andreas Papassotiropoulos,et al.  Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Tanzi,et al.  The genetic epidemiology of neurodegenerative disease. , 2005, The Journal of clinical investigation.

[4]  D. Jeste,et al.  Diagnostic validity of the dementia questionnaire for Alzheimer disease. , 1998, Archives of neurology.

[5]  C. Brayne,et al.  Incidence of Clinically Diagnosed Subtypes of Dementia in an Elderly Population , 1995, British Journal of Psychiatry.

[6]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[7]  A. Myers,et al.  The genetics of late-onset Alzheimer's disease , 2001, Current opinion in neurology.

[8]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele ϵ4 with late‐onset Alzheimer's disease among Finnish centenarians , 1995, Neurology.

[9]  R. Spitzer.  Dsm-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , 1994 .

[10]  D. Marin,et al.  Variability of familial risk of Alzheimer disease across the late life span. , 2005, Archives of general psychiatry.

[11]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[12]  K. Blennow,et al.  A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality , 1998, Journal of neurology, neurosurgery, and psychiatry.

[13]  S. DeKosky,et al.  Association of the 3′ UTR transcription factor LBP‐1c/CP2/LSF polymorphism with late‐onset Alzheimer's disease , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[15]  N. Pedersen,et al.  Genetic influences on memory performance in adulthood: comparison of Minnesota and Swedish twin data. , 1995, Psychology and aging.

[16]  Mitsutoshi Yamamoto,et al.  A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[17]  K. Davis,et al.  A Study of the Reliability of the Family History Method in Genetic Sudies of Alzheimer Disease , 1989, Alzheimer disease and associated disorders.

[18]  L. Thal,et al.  A validation study of the Dementia Questionnaire. , 1994, Archives of neurology.

[19]  K. Davis,et al.  Identifying families with likely genetic protective factors against Alzheimer disease. , 1999, American journal of human genetics.

[20]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[21]  The heritability of cognitive functioning in very old adults: evidence from Danish twins aged 75 years and older. , 2001, Psychology and aging.

[22]  R. Ownby,et al.  Apolipoprotein E Polymorphism and Cognitive Impairment in A Bi-Ethnic Community-Dwelling Elderly Sample , 2002, Alzheimer disease and associated disorders.

[23]  Monique M. B. Breteler,et al.  Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.

[24]  C. W. Adams.  Human longevity. , 1970, Chest.

[25]  W. Barker,et al.  The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease , 2006, Neuroscience Letters.

[26]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. , 1995, Neurology.

[27]  Cathi B. Propper,et al.  Familial patterns of risk in very late-onset Alzheimer disease. , 2003, Archives of general psychiatry.

[28]  K. Davis,et al.  The validity of the family history method for identifying Alzheimer disease. , 1997, Archives of neurology.

[29]  R. Petersen,et al.  Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. , 2002, Archives of neurology.

[30]  A Hofman,et al.  Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.

[31]  J. Growdon,et al.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study , 1996, Neurology.

[32]  M. Folstein,et al.  Familial Alzheimer Dementia: a prevalent disorder with specific clinical features , 1984, Psychological Medicine.

[33]  N. Pedersen,et al.  How heritable is Alzheimer's disease late in life? Findings from Swedish twins , 2004, Annals of neurology.

[34]  D A Bennett,et al.  Gender, cognitive decline, and risk of AD in older persons , 2003, Neurology.

[35]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[36]  Ronald C Petersen,et al.  Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. , 2003, Archives of neurology.

[37]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  J. Kaye,et al.  Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. , 1994, American journal of human genetics.

[39]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[40]  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. , 1986, The American journal of psychiatry.

[41]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[42]  Caleb E. Finch,et al.  The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆ , 1999, Neurobiology of Aging.

[43]  B Johansson,et al.  Substantial genetic influence on cognitive abilities in twins 80 or more years old. , 1997, Science.

[44]  A. Saunders.  Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses , 2000, Journal of neuropathology and experimental neurology.

[45]  R. Sulkava,et al.  APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. , 2000, Neurology.

[46]  J. Haines,et al.  Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives , 1995, Annals of neurology.

[47]  R. Sulkava,et al.  APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old , 2000, Neurology.